Navigation Links
Better treatment sought for blinding traumatic optic nerve damage
Date:4/6/2011

AUGUSTA, Ga. Scientists want to protect the optic nerve when the eye takes a blow on the battlefield or in a car wreck.

It's called traumatic optic nerve damage when the fragile, spaghetti-sized nerve tethered to the back of the eye gets rattled, resulting in swelling and inflammation that can destroy its major component the retinal ganglion nerves causing vision loss and blindness.

"The optic nerve is not completely straight so it can tolerate movement of the head or eyes," said Dr. Julian Nussbaum, Chairman of the Department of Ophthalmology at Georgia Health Sciences University. This extension of the brain also has an insulating myelin sheath and, like the spinal cord, fluid to help protect it.

But as with traumatic brain injury, inflammation and swelling following a concussive injury can still prove deadly.

As with TBIs, few treatment options are available for traumatic optic nerve damage other than high-dose steroids to try to minimize the destructive response. However the nerve's response to these injuries may hold the key to better treatment, said Dr. Gregory Liou, GHSU molecular biologist. He recently received a three-year grant from the U.S. Department of Defense to explore the possibilities.

When an injured nerve cries out for help, the immune system sends pro-inflammatory factors, such as cytokines, to kill off injured neurons and clean up the damage, Liou said. That works pretty well in the peripheral nervous system, the source of nerves for the arms and legs and where nerves can regenerate. But inside the central nervous system, there is little regeneration, Liou said.

To help preserve the balance of Yin and Yang, a nerve injury also produces the energy source adenosine to help combat some of the inflammation. Ironically, inflammation triggers degradation of an enzyme that synthesizes adenosine, the GHSU researchers have found.

"Adenosine is weaker at a time it needs to be stronger," Liou said, noting he wants to strengthen it by giving an agonist that binds to the adenosine receptor so it makes more of the anti-inflammatory substance. "All we are doing is trying to boost the self-defense system that is already there."

He's using a mouse whose ganglion nerves are genetically engineered to glow with exposure to ultraviolet light; they are brightest when healthy, dim when injured and dark when dead. "As the ganglion nerves go, so goes the optic nerve. If you destroy the ganglion cell layer, the optic nerve dies," Nussbaum said. They will inject the A2AAR-selective agonist into the eye and see how it impacts recovery of traumatic optic nerve injury. They believe it will prevent permanent vision damage and give the nerve time to rest and recover.

Nussbaum hopes the treatment will also block inflammation triggered by acute glaucoma, where sky-high pressures inside the eye compress the optic nerve.

A2AAR-selective agonists are showing promise in inflammation-driven diseases such as diabetic retinopathy and nephropathy as well.


'/>"/>

Contact: Toni Baker
tbaker@georgiahealth.edu
706-721-4421
Georgia Health Sciences University
Source:Eurekalert  

Related medicine news :

1. Autism-Related Hypersensitivity Better Understood
2. Developing guidelines for better reporting of health research
3. Hawaiian-shirt.net Offers 10 Tips To Beat The Winter Blues: Things You Can Do Right Now to Have a Better Day
4. Better care at any hour for palliative patients
5. Patients Do Better at Hospitals That Follow Stroke Guidelines
6. More Expensive Hospital Care May Not Mean Better
7. New MRI May Lead to Better Brain Pictures
8. Biological clock could be a key to better health, longer life
9. Why do physicians order costly CTs? Ultrasound yields better diagnosis, safer, less costly
10. BetterInvesting Magazine Releases May Stock to Study and Undervalued Stock Choices for Investors Informational and Educational Use
11. New approach to immune cell analysis seen as first step to better distinguish health and disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Better treatment sought for blinding traumatic optic nerve damage
(Date:9/21/2017)... Falls Church, VA (PRWEB) , ... September 21, ... ... Use Policy , **An FDAnews Management Report**, http://www.fdanews.com/products/54818-promotional-communication      , In the ... every edge they can get while staying in compliance with FDA rules. , ...
(Date:9/21/2017)... WA (PRWEB) , ... September 21, 2017 , ... ... technology using Microscan’s LVS 7510 at the Global GS1 Healthcare Conference 2017 in ... of the life-sciences industry for ensuring label quality and improving patient safety. ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand that ... detail to the athletic wear market with the launch of their FlipBelt Crops. , ... their essentials securely at their fingertips while at the gym, on the trail, or ...
(Date:9/20/2017)... ... September 20, 2017 , ... FirstAlign ( http://www.firstalign.com ), combines ... Artificial Intelligence (AI) thinking, announced today the launch of its revamped web presence. ... information that offers a more comprehensive understanding of the organization’s business and machine ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... and commercialization, has just released a new white paper discussing the benefits ... than ever about medical device, pharmaceutical, and combination product organizations making sure ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)...   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade cell and tissue hypothermic storage and ... , President and CEO, will be presenting at two investment ... Renshaw 19 th Annual Global Investment Conference on Tuesday, ... time). The conference is being held at the New York ...
(Date:9/6/2017)... , Sept. 6, 2017   PDI , a ... it will host an educational session focused on the ... infection (CLABSI) prevention at the 2017 Annual Scientific Meeting ... will take place at the Phoenix ... from Sept. 16-19, will also feature PDI,s ...
(Date:9/5/2017)... -- Sapheneia and Scannerside received FDA 510(k) clearance to ... third-party Vendor neutral CT product that makes it affordable ... current MITA standards. ... specifically designed to provide CT operators, prior to a ... a predefined threshold. Scannerside Dose Check is intended to ...
Breaking Medicine Technology: